{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:45:11Z","timestamp":1792291511154,"version":"4.4.0"},"reference-count":173,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Cardiovascular-Renal-Hepatic-Metabolic (CRHM) syndrome characterizes a complex, interrelated disease framework that encompasses cardiovascular disease, chronic kidney disease (CKD), metabolic dysfunction-associated steatotic liver disease, and metabolic disorders such as obesity, type 2 diabetes mellitus, dyslipidemia, and hypertension. The syndrome extends the concept of cardiovascular-Kidney-Metabolic syndrome by incorporating the liver's pivotal role in systemic metabolic dysfunction. This syndrome progresses through a cycle of chronic inflammation, insulin resistance, oxidative stress, and endothelial dysfunction, driving multi-organ failure and increasing morbidity and mortality. Understanding the mechanistic keystones of this syndrome is critical for refining risk stratification and therapeutic interventions. Traditional inflammatory markers, such as C-reactive protein, interleukin-6, and tumor necrosis factor-alpha, have limitations in predicting long-term disease progression. Emerging biomarkers offer novel insights into systemic disease mechanisms and personalized medicine. Soluble urokinase plasminogen activator receptor has been identified as a stable and predictive marker of systemic inflammation, with strong associations with CKD, atherosclerosis, and coronary artery disease. Galectin-3 is a key regulator of fibrosis and inflammation across multiple organ systems, while Growth Differentiation Factor-15 has been implicated in mitochondrial dysfunction and cardiovascular aging. Furthermore, microRNAs such as miR-126 and miR-423-5p show promise as biomarkers for vascular integrity and heart failure progression, respectively. These biomarkers not only aid in early detection but also guide targeted interventions. Elevated levels of these markers support the use of sodium-glucose cotransporter 2 inhibitors for cardiorenal protection, and glucagon-like peptide-1 receptor agonists or dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 receptor agonists for metabolic and liver-related complications. Despite these advancements, the clinical integration of novel biomarkers remains limited. This review analyzes the pathophysiological mechanisms underlying CRHM syndrome and explores key biomarkers poised to enhance risk assessment and patient monitoring.<\/jats:p>","DOI":"10.3389\/fcvm.2025.1661563","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:44:31Z","timestamp":1761720271000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Pathophysiology and emerging biomarkers of cardiovascular-renal-hepato-metabolic syndrome"],"prefix":"10.3389","volume":"12","author":[{"given":"John","family":"Nzobokela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lweendo","family":"Muchaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alick","family":"Mwambungu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepiso K.","family":"Masenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annet","family":"Kirabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"B1","year":""},{"key":"B2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/biom15020213","article-title":"From cardiovascular-kidney-metabolic syndrome to cardiovascular-renal-hepatic-metabolic syndrome: proposing an expanded framework","volume":"15","author":"Theodorakis","year":"2025","journal-title":"Biomolecules"},{"key":"B3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/biom15030373","article-title":"Cardiovascular\u2013endocrine\u2013metabolic medicine: proposing a new clinical sub-specialty amid the cardiometabolic pandemic","volume":"15","author":"Theodorakis","year":"2025","journal-title":"Biomolecules"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1111\/j.1532-5415.2011.03570.x","article-title":"Interleukin-6, C-reactive protein, tumor necrosis factor-alpha as predictors of mortality in frail, community-living elderly individuals","volume":"59","author":"Giovannini","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"B5","doi-asserted-by":"publisher","first-page":"780641","DOI":"10.3389\/fimmu.2021.780641","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of systemic chronic inflammation","volume":"12","author":"Rasmussen","year":"2021","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI158788","article-title":"Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis","volume":"132","author":"Hindy","year":"2022","journal-title":"J Clin Invest"},{"key":"B7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1056\/NEJMoa1911481","article-title":"Soluble urokinase receptor and acute kidney injury","volume":"382","author":"Hayek","year":"2020","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.tips.2023.06.001","article-title":"Targeting galectin-3 in inflammatory and fibrotic diseases","volume":"44","author":"Bouffette","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"101947","DOI":"10.1016\/j.genrep.2024.101947","article-title":"MiRNA-122 as a biomarker for insulin resistance and risk of cardiovascular diseases in obese children","volume":"36","author":"Abdou","year":"2024","journal-title":"Gene Rep"},{"key":"B10","article-title":"Growth differentiation factor-15 and its role in diabetes and cardiovascular disease","volume":"57","author":"Eddy","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.3390\/nu12113501","article-title":"Metabolic syndrome: past, present and future","volume":"12","author":"Lemieux","year":"2020","journal-title":"Nutrients"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"B14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/00008486-200116020-00005","article-title":"Syndrome X: a tangled web of risk factors for coronary heart disease and diabetes mellitus","volume":"16","author":"Maki","year":"2001","journal-title":"Top Clin Nutr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.2169\/internalmedicine.44.1232","article-title":"Metabolic syndrome amplifies the LDL-cholesterol associated increases in carotid atherosclerosis","volume":"44","author":"Kawamoto","year":"2005","journal-title":"Intern Med Tokyo Jpn"},{"key":"B16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5551\/jat.14.78","article-title":"Metabolic syndrome, diabetes and subclinical atherosclerosis as assessed by carotid intima-media thickness","volume":"14","author":"Kawamoto","year":"2007","journal-title":"J Atheroscler Thromb"},{"key":"B17","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","article-title":"Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative","volume":"31","author":"Ronco","year":"2010","journal-title":"Eur Heart J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3748\/wjg.v30.i2.128","article-title":"Hepatocardiorenal syndrome in liver cirrhosis: recognition of a new entity?","volume":"30","author":"Wu","year":"2024","journal-title":"World J Gastroenterol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1053\/j.akdh.2023.07.002","article-title":"Hepato-cardio-renal syndrome","volume":"31","author":"Koratala","year":"2024","journal-title":"Adv Kidney Dis Health"},{"key":"B21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/biomedicines13010135","article-title":"Integrated management of cardiovascular-renal-hepatic-metabolic syndrome: expanding roles of SGLT2is, GLP-1RAs, and GIP\/GLP-1RAs","volume":"13","author":"Theodorakis","year":"2025","journal-title":"Biomedicines"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-023-01937-x","article-title":"The cardio-renal-metabolic connection: a review of the evidence","volume":"22","author":"Marassi","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"747861","DOI":"10.4061\/2011\/747861","article-title":"Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad","volume":"2011","author":"Raimundo","year":"2011","journal-title":"Cardiol Res Pract"},{"key":"B24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5339\/qmj.2020.22","article-title":"Multiple organ dysfunction syndrome: contemporary insights on the clinicopathological spectrum","volume":"2020","author":"Asim","year":"2020","journal-title":"Qatar Med J"},{"key":"B25","first-page":"100084","article-title":"Endothelial dysfunction and its relation in different disorders: recent update","volume":"7","author":"Ray","year":"2023","journal-title":"Health Sci Rev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J Clin Invest"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1172\/JCI200319451","article-title":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance","volume":"112","author":"Xu","year":"2003","journal-title":"J Clin Invest"},{"key":"B28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00424-017-1955-5","article-title":"Macrophage function in obesity-induced inflammation and insulin resistance","volume":"469","author":"Lauterbach","year":"2017","journal-title":"Pflugers Arch"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.3390\/cells11193001","article-title":"Macrophages, chronic inflammation, and insulin resistance","volume":"11","author":"Li","year":"2022","journal-title":"Cells"},{"key":"B30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","article-title":"NF-\u03baB, inflammation and metabolic disease","volume":"13","author":"Baker","year":"2011","journal-title":"Cell Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.752337","article-title":"Recent advances in understanding the role of IKK\u03b2 in cardiometabolic diseases","volume":"8","author":"Hernandez","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e202101286","DOI":"10.26508\/lsa.202101286","article-title":"Obesity-induced senescent macrophages activate a fibrotic transcriptional program in adipocyte progenitors","volume":"5","author":"Rabhi","year":"2022","journal-title":"Life Sci Alliance"},{"key":"B33","first-page":"e21417","article-title":"Single-cell RNA sequencing reveals the induction of novel myeloid and myeloid-associated cell populations in visceral fat with long-term obesity","volume":"35","author":"Harasymowicz","year":"2021","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1172\/JCI26498","article-title":"MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity","volume":"116","author":"Kanda","year":"2006","journal-title":"J Clin Invest"},{"key":"B35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s10142-025-01587-0","article-title":"Autoimmune mechanisms and inflammation in obesity-associated type 2 diabetes, atherosclerosis, and non-alcoholic fatty liver disease","volume":"25","author":"Sun","year":"2025","journal-title":"Funct Integr Genomics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.3390\/cells12222621","article-title":"Neutrophils in inflammatory diseases: unraveling the impact of their derived molecules and heterogeneity","volume":"12","author":"Riaz","year":"2023","journal-title":"Cells"},{"key":"B37","first-page":"1","article-title":"Role of macrophages in oxidative stress induced inflammatory tumor microenvironment","volume-title":"Handbook of Oxidative Stress in Cancer: Mechanistic Aspects","author":"Teli","year":"2020"},{"key":"B38","doi-asserted-by":"publisher","first-page":"9739","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/cells7080096","article-title":"Association of NF-\u03baB and AP-1 with MMP-9 overexpression in 2-chloroethanol exposed rat astrocytes","volume":"7","author":"Wang","year":"2018","journal-title":"Cells"},{"key":"B40","doi-asserted-by":"publisher","first-page":"14351","DOI":"10.1038\/s41598-023-41514-6","article-title":"TNF\u03b1 induces matrix metalloproteinase-9 expression in monocytic cells through ACSL1\/JNK\/ERK\/NF-kB signaling pathways","volume":"13","author":"Al-Roub","year":"2023","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","article-title":"Neutrophils in chronic inflammatory diseases","volume":"19","author":"Herrero-Cervera","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1149239","DOI":"10.3389\/fendo.2023.1149239","article-title":"The crucial role and mechanism of insulin resistance in metabolic disease","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Endocrinol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fcvm.2020.00022","article-title":"Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease","volume":"7","author":"Chait","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"14982","DOI":"10.3390\/ijms232314982","article-title":"The role of adipokines in inflammatory mechanisms of obesity","volume":"23","author":"Kirichenko","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.jacc.2008.05.060","article-title":"Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease","volume":"52","author":"Martin","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"15330","DOI":"10.3390\/ijms232315330","article-title":"The PI3K\/akt pathway in meta-inflammation","volume":"23","author":"Acosta-Martinez","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2017.02.021","article-title":"PKC-epsilon and TLR4 synergistically regulate resistin-mediated inflammation in human macrophages","volume":"259","author":"Zuniga","year":"2017","journal-title":"Atherosclerosis"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.2337\/diabetes.48.6.1270","article-title":"Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade","volume":"48","author":"Griffin","year":"1999","journal-title":"Diabetes"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.2337\/diabetes.51.7.2005","article-title":"Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha","volume":"51","author":"Itani","year":"2002","journal-title":"Diabetes"},{"key":"B50","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1111\/apt.17930","article-title":"Pathogenesis of MASLD and MASH\u2014role of insulin resistance and lipotoxicity","volume":"59","author":"Bansal","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"B51","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.cmet.2024.04.006","article-title":"Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease","volume":"36","author":"Bo","year":"2024","journal-title":"Cell Metab"},{"key":"B52","doi-asserted-by":"publisher","first-page":"E718","DOI":"10.1152\/ajpendo.00156.2003","article-title":"Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice","volume":"285","author":"Altomonte","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B53","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.bone.2011.06.034","article-title":"Foxo1, the transcriptional chief of staff of energy metabolism","volume":"50","author":"Kousteni","year":"2012","journal-title":"Bone"},{"key":"B54","doi-asserted-by":"publisher","first-page":"771","DOI":"10.5551\/jat.RV17023","article-title":"Pathophysiology of diabetic dyslipidemia","volume":"25","author":"Hirano","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"B55","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.cmet.2012.03.005","article-title":"Diacylglycerol activation of protein kinase c\u03b5 and hepatic insulin resistance","volume":"15","author":"Jornayvaz","year":"2012","journal-title":"Cell Metab"},{"key":"B56","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.3390\/ijms21176043","article-title":"Mitochondrial dysfunction in diabetic cardiomyopathy: the possible therapeutic roles of phenolic acids","volume":"21","author":"Jubaidi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B57","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fphys.2020.00084","article-title":"NF-\u03baB system is chronically activated and promotes glomerular injury in experimental type 1 diabetic kidney disease","volume":"11","author":"Foresto-Neto","year":"2020","journal-title":"Front Physiol"},{"key":"B58","first-page":"287","article-title":"First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence grid","volume":"54","author":"Ighodaro","year":"2018","journal-title":"Alex J Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3390\/cancers17071169","article-title":"In the era of cardiovascular\u2013kidney\u2013metabolic syndrome in cardio-oncology: from pathogenesis to prevention and therapy","volume":"17","author":"Quagliariello","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.1000578\/full","article-title":"Advances in the study of nicotinamide adenine dinucleotide phosphate oxidase in myocardial remodeling","volume":"9","author":"Miao","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"102968","DOI":"10.1016\/j.cpcardiol.2024.102968","article-title":"Mitochondrial dysfunction and calcium homeostasis in heart failure: exploring the interplay between oxidative stress and cardiac remodeling for future therapeutic innovations","volume":"50","author":"Johnson","year":"2025","journal-title":"Curr Probl Cardiol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"103576","DOI":"10.1016\/j.autrev.2024.103576","article-title":"The role of mitochondrial dysfunction in kidney injury and disease","volume":"23","author":"Jia","year":"2024","journal-title":"Autoimmun Rev"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.7150\/thno.81240","article-title":"NOX4 is a potential therapeutic target in septic acute kidney injury by inhibiting mitochondrial dysfunction and inflammation","volume":"13","author":"Li","year":"2023","journal-title":"Theranostics"},{"key":"B64","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/medicina55020026","article-title":"Oxidative stress and antioxidant biomarkers in clinical and experimental models of non-alcoholic fatty liver disease","volume":"55","author":"Ore","year":"2019","journal-title":"Medicina (Mex)"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.ajpath.2023.08.007","article-title":"The role of endoplasmic reticulum in lipotoxicity during metabolic dysfunction\u2013associated steatotic liver disease (MASLD) pathogenesis","volume":"193","author":"Venkatesan","year":"2023","journal-title":"Am J Pathol"},{"key":"B66","first-page":"569654","article-title":"Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes","volume":"2012","author":"Funk","year":"2012","journal-title":"Int J Vasc Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3390\/biomedicines10051168","article-title":"Inflammatory mechanisms of diabetes and its vascular complications","volume":"10","author":"Nedosugova","year":"2022","journal-title":"Biomedicines"},{"key":"B68","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.3390\/ijms26083707","article-title":"The advanced glycation End-products (AGE)\u2013receptor for AGE system (RAGE): an inflammatory pathway linking obesity and cardiovascular diseases","volume":"26","author":"Vianello","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: sparking the development of diabetic vascular injury","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation"},{"key":"B70","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.freeradbiomed.2022.03.019","article-title":"Oxidative stress in the pathophysiology of type 2 diabetes and related complications: current therapeutics strategies and future perspectives","volume":"184","author":"Bhatti","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.3390\/antiox13121454","article-title":"Oxidative stress in kidney injury and hypertension","volume":"13","author":"Arendshorst","year":"2024","journal-title":"Antioxidants"},{"key":"B72","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/s41401-024-01235-6","article-title":"Transforming growth factor-\u03b2 receptors: versatile mechanisms of ligand activation","volume":"45","author":"Chia","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"B74","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/livers2010003","article-title":"Oxidative stress in non-alcoholic fatty liver disease","volume":"2","author":"Smirne","year":"2022","journal-title":"Livers"},{"key":"B75","doi-asserted-by":"publisher","first-page":"360438","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxid Med Cell Longev"},{"key":"B76","doi-asserted-by":"publisher","first-page":"125472","DOI":"10.1016\/j.chemosphere.2019.125472","article-title":"Inhibition of the mitochondrial respiratory components (Complex I and Complex III) as stimuli to induce oxidative damage in Oryza sativa L. Under thiocyanate exposure","volume":"243","author":"Lin","year":"2020","journal-title":"Chemosphere"},{"key":"B77","doi-asserted-by":"publisher","first-page":"4234061","DOI":"10.1155\/2016\/4234061","article-title":"Insights into the role and interdependence of oxidative stress and inflammation in liver diseases","volume":"2016","author":"Li","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"B78","doi-asserted-by":"publisher","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","article-title":"Oxidative stress and heart failure","volume":"301","author":"Tsutsui","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"4578175","DOI":"10.1155\/2019\/4578175","article-title":"NADPH oxidase hyperactivity contributes to cardiac dysfunction and apoptosis in rats with severe experimental pancreatitis through ROS-mediated MAPK signaling pathway","volume":"2019","author":"Wen","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"B80","doi-asserted-by":"publisher","first-page":"9255","DOI":"10.3390\/ijms25179255","article-title":"Reactive oxygen Species mechanisms that regulate protein\u2013protein interactions in cancer","volume":"25","author":"Iliadis","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"10873","DOI":"10.1038\/s41467-024-55168-z","article-title":"Hidden route of protein damage through oxygen-confined photooxidation","volume":"15","author":"Kim","year":"2024","journal-title":"Nat Commun"},{"key":"B82","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.3390\/ijms22094642","article-title":"The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies","volume":"22","author":"Juan","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B83","doi-asserted-by":"publisher","first-page":"32967","DOI":"10.1074\/jbc.M112.400663","article-title":"Protein carbonylation and adipocyte mitochondrial function","volume":"287","author":"Curtis","year":"2012","journal-title":"J Biol Chem"},{"key":"B84","doi-asserted-by":"publisher","first-page":"844","DOI":"10.3390\/antiox12040844","article-title":"Carbonylated proteins as key regulators in the progression of metabolic syndrome","volume":"12","author":"Kitamura","year":"2023","journal-title":"Antioxidants"},{"key":"B85","first-page":"83","article-title":"Mitochondrial regulation of diabetic vascular disease: an emerging opportunity","volume":"202","author":"Widlansky","year":"2018","journal-title":"Transl Res J Lab Clin Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00125-003-1097-5","article-title":"IRS1 degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stress","volume":"46","author":"Potashnik","year":"2003","journal-title":"Diabetologia"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1089\/ars.2014.5994","article-title":"Redox regulation of NLRP3 inflammasomes: rOS as trigger or effector?","volume":"22","author":"Abais","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"B88","doi-asserted-by":"publisher","first-page":"8221","DOI":"10.3390\/ijms22158221","article-title":"CYP2E1 in alcoholic and non-alcoholic liver injury. Roles of ROS, reactive intermediates and lipid overload","volume":"22","author":"Harjum\u00e4ki","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B89","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/antiox14040461","article-title":"Hyperphosphataemia and NADPH oxidase regulation in pathophysiological processes: implications for oxidative stress and disease progression","volume":"14","author":"Lacerda-Abreu","year":"2025","journal-title":"Antioxidants"},{"key":"B90","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.freeradbiomed.2018.06.042","article-title":"Nox4 in renal diseases: an update","volume":"124","author":"Yang","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jchf.2023.09.027","article-title":"Myocardial DNA damage predicts heart failure outcome in Various underlying diseases","volume":"12","author":"Dai","year":"2024","journal-title":"JACC Heart Fail"},{"key":"B92","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.healun.2020.01.1155","article-title":"Single-cell RNA-Seq of human cardiomyocytes revealed DNA damage response as a novel predictor for therapeutic prognosis in heart failure patients with dilated cardiomyopathy","volume":"39","author":"Ko","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"B93","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1038\/s41467-025-59297-x","article-title":"DNA damage in proximal tubules triggers systemic metabolic dysfunction through epigenetically altered macrophages","volume":"16","author":"Nishimura","year":"2025","journal-title":"Nat Commun"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1162546\/full","article-title":"Roles of DNA damage in renal tubular epithelial cells injury","volume":"14","author":"Wang","year":"2023","journal-title":"Front Physiol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"e651","DOI":"10.1002\/mco2.651","article-title":"Endothelial dysfunction: molecular mechanisms and clinical implications","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm"},{"key":"B96","doi-asserted-by":"publisher","first-page":"670076","DOI":"10.3389\/fphar.2021.670076","article-title":"Coordinated contribution of NADPH oxidase- and mitochondria-derived reactive oxygen species in metabolic syndrome and its implication in renal dysfunction","volume":"12","author":"Lee","year":"2021","journal-title":"Front Pharmacol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"7898","DOI":"10.3390\/ijms24097898","article-title":"Mechanisms of oxidative stress in metabolic syndrome","volume":"24","author":"Masenga","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B98","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1471-2148-7-109","article-title":"Molecular evolution of the reactive oxygen-generating NADPH oxidase (nox\/duox) family of enzymes","volume":"7","author":"Kawahara","year":"2007","journal-title":"BMC Evol Biol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3390\/antiox11061131","article-title":"NADPH oxidases connecting fatty liver disease, insulin resistance and type 2 diabetes: current knowledge and therapeutic outlook","volume":"11","author":"Nasc\u00e8","year":"2022","journal-title":"Antioxidants"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-024-07219-w","article-title":"Cellular and molecular roles of reactive oxygen species in wound healing","volume":"7","author":"Hunt","year":"2024","journal-title":"Commun Biol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen Species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"B102","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1161\/01.ATV.0000258979.92828.bc","article-title":"Reactive oxygen species activate the HIF-1\u03b1 promoter via a functional NF\u03baB site","volume":"27","author":"Bonello","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"e12895","DOI":"10.14814\/phy2.12895","article-title":"Hyperinsulinemia augments endothelin-1 protein expression and impairs vasodilation of human skeletal muscle arterioles","volume":"4","author":"Mahmoud","year":"2016","journal-title":"Physiol Rep"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01964-8","article-title":"Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease","volume":"22","author":"Smeijer","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"sfae072","DOI":"10.1093\/ckj\/sfae072","article-title":"Endothelin receptor antagonists in diabetic and non-diabetic chronic kidney disease","volume":"17","author":"Ivkovi\u0107","year":"2024","journal-title":"Clin Kidney J"},{"key":"B106","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/biom12040542","article-title":"Advanced glycation end products and diabetes mellitus: mechanisms and perspectives","volume":"12","author":"Khalid","year":"2022","journal-title":"Biomolecules"},{"key":"B107","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4330\/wjc.v4.i4.90","article-title":"Role of advanced glycation end products in cardiovascular disease","volume":"4","author":"Hegab","year":"2012","journal-title":"World J Cardiol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"590","DOI":"10.14336\/AD.2017.0430","article-title":"Age-related impairment of vascular structure and functions","volume":"8","author":"Xu","year":"2017","journal-title":"Aging Dis"},{"key":"B109","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4161\/oxim.3.2.11148","article-title":"Advanced glycation end products, oxidative stress and diabetic nephropathy","volume":"3","author":"Yamagishi","year":"2010","journal-title":"Oxid Med Cell Longev"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.970423\/full","article-title":"RAGE pathway activation and function in chronic kidney disease and COVID-19","volume":"9","author":"Curran","year":"2022","journal-title":"Front Med"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1128872\/full","article-title":"RAGE signaling regulates the progression of diabetic complications","volume":"14","author":"Taguchi","year":"2023","journal-title":"Front Pharmacol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"977247","DOI":"10.3389\/fphys.2022.977247","article-title":"Advanced glycation endproducts mediate chronic kidney injury with characteristic patterns in different stages","volume":"13","author":"Huang","year":"2022","journal-title":"Front Physiol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3390\/biomedicines9070781","article-title":"Inflammatory mechanisms contributing to endothelial dysfunction","volume":"9","author":"Theofilis","year":"2021","journal-title":"Biomedicines"},{"key":"B114","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/CIRCRESAHA.123.321752","article-title":"Endothelial cell dysfunction and increased cardiovascular risk in patients with chronic kidney disease","volume":"132","author":"Baaten","year":"2023","journal-title":"Circ Res"},{"key":"B115","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/cells10010051","article-title":"Role of cardiac macrophages on cardiac inflammation, fibrosis and tissue repair","volume":"10","author":"Lafuse","year":"2021","journal-title":"Cells"},{"key":"B116","first-page":"e51066","article-title":"Insulin resistance and coronary artery disease: untangling the web of endocrine-cardiac connections","volume":"15","author":"Ashraf","year":"2023","journal-title":"Cureus"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1656450","DOI":"10.1155\/2016\/1656450","article-title":"The role of oxidative stress in myocardial ischemia and reperfusion injury and remodeling: revisited","volume":"2016","author":"Kurian","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"B118","first-page":"136","article-title":"Mechanisms and clinical implications of endothelial dysfunction in arterial hypertension","volume":"9","author":"Ambrosino","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"B119","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1038\/ki.2008.516","article-title":"Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease: new strategies to prevent cardiovascular risk in chronic kidney disease","volume":"74","author":"Cachofeiro","year":"2008","journal-title":"Kidney Int"},{"key":"B120","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3390\/antiox9080752","article-title":"Chronic kidney disease as oxidative stress- and inflammatory-mediated cardiovascular disease","volume":"9","author":"Podkowi\u0144ska","year":"2020","journal-title":"Antioxidants"},{"key":"B121","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/metabo14030153","article-title":"Interleukins: pathogenesis in non-alcoholic fatty liver disease","volume":"14","author":"Rafaqat","year":"2024","journal-title":"Metabolites"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.708959\/full","article-title":"Crosstalk between plasma cytokines, inflammation, and liver damage as a new strategy to monitoring NAFLD progression","volume":"12","author":"Fontes-Cal","year":"2021","journal-title":"Front Immunol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"101497","DOI":"10.1016\/j.diabet.2023.101497","article-title":"MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus","volume":"50","author":"Mantovani","year":"2024","journal-title":"Diabetes Metab"},{"key":"B124","doi-asserted-by":"publisher","first-page":"101092","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol Metab"},{"key":"B125","doi-asserted-by":"publisher","first-page":"586569","DOI":"10.1155\/2015\/586569","article-title":"Cardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicability","volume":"2015","author":"D\u2019Marco","year":"2015","journal-title":"Dis Markers"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506362","article-title":"Soluble urokinase receptor and chronic kidney disease","author":"Hayek","year":"2015","journal-title":"New Engl J Medi"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00424-017-2026-7","article-title":"suPAR and chronic kidney disease\u2014a podocyte story","volume":"469","author":"Zeier","year":"2017","journal-title":"Pfl\u00fcg Arch"},{"key":"B128","doi-asserted-by":"publisher","first-page":"A4132351","DOI":"10.1161\/circ.150.suppl_1.4132351","article-title":"Abstract 4132351: soluble urokinase plasminogen activator receptor levels predict incident cardio-kidney-metabolic disease risk","volume":"150","author":"Yadalam","year":"2024","journal-title":"Circulation"},{"key":"B129","doi-asserted-by":"publisher","first-page":"132071","DOI":"10.1016\/j.ijcard.2024.132071","article-title":"Prognostic performance of soluble urokinase plasminogen activator receptor for heart failure or mortality in western and Asian patients with acute breathlessness","volume":"406","author":"Chew-Harris","year":"2024","journal-title":"Int J Cardiol"},{"key":"B130","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/j.jtct.2024.01.016","article-title":"Soluble urokinase-type plasminogen activator receptor (suPAR) as a biomarker of acute kidney injury requiring dialysis (AKI-D) in patients undergoing allogeneic hematopoietic cell transplantation (HCT): results from the blood and marrow transplant clinical trials network 1202 study","volume":"30","author":"Bhasin-Chhabra","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"B131","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1007\/s00431-024-05496-5","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) in children with obesity or type 1 diabetes as a marker of endothelial dysfunction: a cross-sectional study","volume":"183","author":"Kostopoulou","year":"2024","journal-title":"Eur J Pediatr"},{"key":"B132","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3390\/biomedicines10030585","article-title":"Urinary galectin-3 as a novel biomarker for the prediction of renal fibrosis and kidney disease progression","volume":"10","author":"Ou","year":"2022","journal-title":"Biomedicines"},{"key":"B133","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/biom12010046","article-title":"The diagnostic and therapeutic potential of galectin-3 in cardiovascular diseases","volume":"12","author":"Sygitowicz","year":"2022","journal-title":"Biomolecules"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.854501\/full","article-title":"Clinical implications of plasma galectin-3 in heart failure with preserved ejection fraction: a meta-analysis","volume":"9","author":"Shi","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.783707\/full","article-title":"Prognostic value of serum galectin-3 in chronic heart failure: a meta-analysis","volume":"9","author":"Cheng","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.829151\/full","article-title":"Diagnostic value of Serum concentration of galectin-3 in patients with heart failure with preserved ejection fraction","volume":"8","author":"Jiang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B137","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000513663","article-title":"Soluble ST2 and galectin-3 as predictors of chronic kidney disease progression and outcomes","volume":"52","author":"Kim","year":"2021","journal-title":"Am J Nephrol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3390\/toxins13080532","article-title":"Serum galectin-3 level is positively associated with endothelial dysfunction in patients with chronic kidney disease stage 3 to 5","volume":"13","author":"Hsu","year":"2021","journal-title":"Toxins (Basel)"},{"key":"B139","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2174\/0109298665301698240404061300","article-title":"Galectin-3 and severity of liver fibrosis in metabolic dysfunction-associated fatty liver disease","volume":"31","author":"Sotoudeheian","year":"2024","journal-title":"Protein Pept Lett"},{"key":"B140","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/jcp.30956","article-title":"Unraveling the pathophysiologic role of galectin-3 in chronically injured liver","volume":"238","author":"Ezhilarasan","year":"2023","journal-title":"J Cell Physiol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ajg.2021.03.002","article-title":"Comparison between galectin-3 and YKL-40 levels for the assessment of liver fibrosis in cirrhotic patients","volume":"22","author":"Del Turco","year":"2021","journal-title":"Arab J Gastroenterol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/17512433.2021.1894127","article-title":"Review of galectin-3 inhibitors in the treatment of nonalcoholic steatohepatitis","volume":"14","author":"Al Attar","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4254\/wjh.v15.i2.201","article-title":"Galectin-3 inhibition as a potential therapeutic target in non-alcoholic steatohepatitis liver fibrosis","volume":"15","author":"Kram","year":"2023","journal-title":"World J Hepatol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2019.11.296","article-title":"Effects of belapectin, an inhibitor of galectin-3, in patients with nonalcoholic steatohepatitis with cirrhosis and portal hypertension","volume":"158","author":"Chalasani","year":"2020","journal-title":"Gastroenterology"},{"key":"B145","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejim.2021.02.011","article-title":"Growth differentiation factor-15 predicts major adverse cardiac events and all-cause mortality in patients with atrial fibrillation","volume":"88","author":"Nopp","year":"2021","journal-title":"Eur J Intern Med"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e35916","article-title":"Association between growth differentiation factor-15 and adverse outcomes among patients with heart failure: a systematic literature review","volume":"10","author":"Javaheri","year":"2024","journal-title":"Heliyon"},{"key":"B147","doi-asserted-by":"publisher","first-page":"e015521","DOI":"10.1161\/JAHA.119.015521","article-title":"GDF-15 (growth differentiation factor 15) is associated with hospitalization and mortality in patients with a fontan circulation","volume":"9","author":"Meyer","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B148","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/hepr.14148","article-title":"Circulating and hepatic levels of growth differentiation factor 15 in patients with metabolic dysfunction-associated steatotic liver disease","volume":"55","author":"Werge","year":"2025","journal-title":"Hepatol Res"},{"key":"B149","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41387-021-00170-3","article-title":"Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD","volume":"11","author":"Bilson","year":"2021","journal-title":"Nutr Diabetes"},{"key":"B150","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13098-023-01163-1","article-title":"Association of N-terminal pro-B-type natriuretic peptide levels and mortality risk in acute myocardial infarction across body mass index categories: an observational cohort study","volume":"15","author":"Wang","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"B151","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s12020-024-04157-9","article-title":"Assessing the risk of heart failure in type 2 diabetes: a prediction algorithm to sustain the evaluation of NT-proBNP in primary care","volume":"88","author":"Lapi","year":"2025","journal-title":"Endocrine"},{"key":"B152","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s00125-024-06299-x","article-title":"NT-proBNP improves prediction of cardiorenal complications in type 2 diabetes: the Hong Kong diabetes biobank","volume":"68","author":"Ma","year":"2025","journal-title":"Diabetologia"},{"key":"B153","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10741-024-10442-6","article-title":"BNP and NT-proBNP as prognostic biomarkers for the prediction of adverse outcomes in HFpEF patients: a systematic review and meta-analysis","volume":"30","author":"Ammar","year":"2025","journal-title":"Heart Fail Rev"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2024-324685","article-title":"Association between NT-proBNP levels and risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies","author":"Wang","year":"2025","journal-title":"BMJ"},{"key":"B155","doi-asserted-by":"publisher","first-page":"120249","DOI":"10.1016\/j.cca.2025.120249","article-title":"A novel NT-proBNP assay for heart failure diagnosis: a prospective, multicenter clinical trial","volume":"572","author":"Guidi","year":"2025","journal-title":"Clin Chim Acta"},{"key":"B156","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1161\/CIRCULATIONAHA.124.071079","article-title":"Albuminuria in cardiovascular, kidney, and metabolic disorders: a state-of-the-art review","volume":"151","author":"Claudel","year":"2025","journal-title":"Circulation"},{"key":"B157","doi-asserted-by":"crossref","first-page":"e040890","DOI":"10.1136\/bmjopen-2020-040890","article-title":"Urinary albumin-to-creatinine ratio levels are associated with subclinical atherosclerosis and predict CVD events and all-cause deaths: a prospective analysis","volume":"11","author":"Liu","year":"2021","journal-title":"BMJ Open"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.864562\/full","article-title":"High normal urinary albumin\u2013creatinine ratio is associated with hypertension, type 2 diabetes Mellitus, HTN with T2DM, dyslipidemia, and cardiovascular diseases in the Chinese population: a report from the REACTION study","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.numecd.2009.02.013","article-title":"Obesity and changes in urine albumin\/creatinine ratio in patients with type 2 diabetes: the DEMAND study","volume":"20","author":"Rossi","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B160","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1053\/j.ajkd.2023.12.018","article-title":"Urine albumin-creatinine ratio variability in people with type 2 diabetes: clinical and research implications","volume":"84","author":"Rasaratnam","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"B161","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejim.2023.04.013","article-title":"High miR-126-3p levels associated with cardiovascular events in a general population","volume":"113","author":"Martinez-Arroyo","year":"2023","journal-title":"Eur J Intern Med"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.944317\/full","article-title":"Diagnostic value of cardiac miR-126-5p, miR-134-5p, and miR-499a-5p in coronary artery disease-induced sudden cardiac death","volume":"9","author":"Li","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B163","doi-asserted-by":"publisher","first-page":"6430","DOI":"10.3390\/ijms25126430","article-title":"MicroRNA expression in patients with coronary artery disease and hypertension\u2014a systematic review","volume":"25","author":"Kondracki","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B164","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.2147\/IJGM.S338147","article-title":"LncRNA FENDRR servers as a possible marker of essential hypertension and regulates human umbilical vein endothelial cells dysfunction via miR-423-5p\/Nox4 axis","volume":"15","author":"Zhao","year":"2022","journal-title":"Int J Gen Med"},{"key":"B165","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13019-024-03091-1","article-title":"Diagnostic and prognostic value of microRNA423-5p in patients with heart failure","volume":"19","author":"Guo","year":"2024","journal-title":"J Cardiothorac Surg"},{"key":"B166","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"B167","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"Herrington","year":"2023","journal-title":"N Engl J Med"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"B169","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"B170","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N Engl J Med"},{"key":"B171","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N Engl J Med"},{"key":"B172","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s10741-009-9139-9","article-title":"Biomarker guided therapy for heart failure: focus on natriuretic peptides","volume":"15","author":"Adams","year":"2010","journal-title":"Heart Fail Rev"},{"key":"B173","doi-asserted-by":"publisher","first-page":"17539447231177175","DOI":"10.1177\/17539447231177175","article-title":"Lifestyle or pharmacotherapy in cardio-metabolic disease prevention","volume":"17","author":"Seidu","year":"2023","journal-title":"Ther Adv Cardiovasc Dis"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1661563\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:44:34Z","timestamp":1761720274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1661563\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":173,"alternative-id":["10.3389\/fcvm.2025.1661563"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1661563","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"article-number":"1661563"}}